These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2567012)

  • 1. Structure-activity relationships of H2-receptor histamine antagonists based on quantum chemical methods.
    Luque FJ; Illas F; Pouplana R
    Prog Clin Biol Res; 1989; 291():373-6. PubMed ID: 2567012
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantum mechanics in structure-based drug design.
    Peters MB; Raha K; Merz KM
    Curr Opin Drug Discov Devel; 2006 May; 9(3):370-9. PubMed ID: 16729734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target-related applications of first principles quantum chemical methods in drug design.
    Cavalli A; Carloni P; Recanatini M
    Chem Rev; 2006 Sep; 106(9):3497-519. PubMed ID: 16967914
    [No Abstract]   [Full Text] [Related]  

  • 4. New activation model for the histamine H2 receptor, explaining the activity of the different classes of histamine H2 receptor agonists.
    Eriks JC; van der Goot H; Timmerman H
    Mol Pharmacol; 1993 Oct; 44(4):886-94. PubMed ID: 8232239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential histamine H2-receptor antagonists. Synthesis, structure and activity of a few open models related to classical H2-antagonists.
    Sorba G; Fruttero R; Gasco A; Orsetti M
    Arzneimittelforschung; 1989 Sep; 39(9):1092-6. PubMed ID: 2574039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the structure-activity relationship of histamine H2-receptor antagonists based on the X-ray crystal structures and 1H-NMR spectra of amidine derivatives.
    Ishida T; In Y; Shibata M; Doi M; Inoue M; Yanagisawa I
    Mol Pharmacol; 1987 Apr; 31(4):410-6. PubMed ID: 2883568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A conformational approach to histamine H2-receptor antagonists.
    Bianucci AM; Martinelli A; Da Settimo A
    Farmaco Sci; 1984 Aug; 39(8):686-95. PubMed ID: 6148263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrophobic similarity between molecules: a MST-based hydrophobic similarity index.
    Muñoz J; Barril X; Hernández B; Orozco M; Luque FJ
    J Comput Chem; 2002 Apr; 23(5):554-63. PubMed ID: 11948582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [H2-antagonistic activity of the impromidine analog, cyanoguanidine. 37. H2 antihistaminics].
    Elz S; Schunack W
    Arzneimittelforschung; 1988 Jan; 38(1):7-10. PubMed ID: 2896510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity of H2-receptor antagonists to isolated rat hepatocytes: structure-activity relationships.
    Rush GF; Alberts D; Lupo S; Yodis LA; Brown TH; Durant GJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):113-7. PubMed ID: 2891842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecular theory of recognition and activation at a 5-HT receptor based on a quantum chemical approach to structure activity relationships.
    Osman R; Weinstein H; Topiol S; Rubenstein L
    Clin Physiol Biochem; 1985; 3(2-3):80-8. PubMed ID: 4006382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of structure-activity relationships for neurotransmitters using molecular electric field mapping: histamine and some of its H2-receptor agonists.
    Nair AC; Mishra PC
    Indian J Biochem Biophys; 1994 Dec; 31(6):496-500. PubMed ID: 7875722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of quantum mechanics in structure-based drug design.
    Raha K; Peters MB; Wang B; Yu N; Wollacott AM; Westerhoff LM; Merz KM
    Drug Discov Today; 2007 Sep; 12(17-18):725-31. PubMed ID: 17826685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, structure-activity relationships, X-ray crystal structure, and energetic contributions of a critical P1 pharmacophore: 3-chloroindole-7-yl-based factor Xa inhibitors.
    Shi Y; Sitkoff D; Zhang J; Klei HE; Kish K; Liu EC; Hartl KS; Seiler SM; Chang M; Huang C; Youssef S; Steinbacher TE; Schumacher WA; Grazier N; Pudzianowski A; Apedo A; Discenza L; Yanchunas J; Stein PD; Atwal KS
    J Med Chem; 2008 Dec; 51(23):7541-51. PubMed ID: 18998662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and assessment of formamidines as new histamine H2-receptor antagonists.
    Anglada L; Raga M; Márquez M; Sacristán A; Castelló JM; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):431-4. PubMed ID: 9205738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel carbamates as potent histamine H3 receptor antagonists with high in vitro and oral in vivo activity.
    Stark H; Purand K; Ligneau X; Rouleau A; Arrang JM; Garbarg M; Schwartz JC; Schunack W
    J Med Chem; 1996 Mar; 39(5):1157-63. PubMed ID: 8676353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of H2-receptor antagonists cimetidine, ranitidine, and ICI 125,211 on histamine-stimulated adenylate cyclase activity in guinea pig gastric mucosa.
    Cheret AM; Pignal F; Lewin MJ
    Mol Pharmacol; 1981 Sep; 20(2):326-30. PubMed ID: 6117786
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis, structure and activity of a few open models related to classic H2-antagonists.
    Fruttero R; Sorba G; Gasco A
    Farmaco Sci; 1988 Dec; 43(12 Suppl):1131-40. PubMed ID: 2907740
    [No Abstract]   [Full Text] [Related]  

  • 19. [Alkyl- and alkoxy-substituted lamtidine analogs: synthesis and H2-antagonistic activity. 38. H2-antihistaminics].
    Bonjean VJ; Schunack W
    Arzneimittelforschung; 1988 Apr; 38(4):501-7. PubMed ID: 2900010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and activity of pyridine analogues of histamine H2-receptor antagonists.
    Agrawal VK; Tang SB; Wolowyk MW; Knaus EE
    Drug Des Deliv; 1988 Dec; 3(4):297-307. PubMed ID: 2908227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.